Treatment of cervical cancer: overcoming challenges in access to brachytherapy

Expert Rev Anticancer Ther. 2022 Apr;22(4):353-359. doi: 10.1080/14737140.2022.2047936. Epub 2022 Mar 20.

Abstract

Introduction: Brachytherapy is an essential component of the cervical cancer treatment paradigm as it contributes to improved clinical outcomes and overall survival. Yet brachytherapy remains globally underutilized, with disparities in access at both national and international levels.

Areas covered: The review explores current brachytherapy utilization practices and efforts being undertaken to address barriers to implementation in low-, middle-, and high-income countries, and how these efforts are projected to impact future brachytherapy access. The content presented is based on a review of published literature and the authors' collective clinical experiences.

Expert opinion: There exists a tremendous opportunity to expand access to essential brachytherapy services for women with cervical cancer. Many national and international brachytherapy efforts exist; yet it remains imperative that such focused efforts continue to grow and provide further access to this critical treatment modality for women in need worldwide.

Keywords: Brachytherapy; Cervix Cancer; global health; global oncology; gynecologic cancer; health disparities; medication education; radiation oncology; radiotherapy.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Brachytherapy*
  • Female
  • Humans
  • Radiotherapy Dosage
  • Uterine Cervical Neoplasms* / radiotherapy